Aurobindo Pharma gets official action indicated status from USFDA; shares trade lower
Aurobindo Pharma | The company had reported 80 percent rise in consolidated net profit to Rs 909 crore in the Jan-March quarter of FY24 from Rs 508 crore in the same period a year ago.